Breast Cancer - Adjuvant Tamoxifen Improves 15-Year Survival By One Third

For women with breast cancer who take adjuvant Tamoxifen daily for 5 years, their risk of dying from the disease drops by one third, compared to their chances without the drug, researchers reported in The Lancet today. They referred specifically to women with estrogen-receptor positive breast cancer, also known as hormone-sensitive breast cancer. After effective breast cancer surgery, various treatments can be given to prevent recurrence of the disease and possibly death. The authors explained that several trials have been conducted in this area of medicine...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/LMKlB-U1PGY/231980.php

rehab sport sport medical